| Effect | Increase |
| Trial Design | Non-randomized controlled trial |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 6 |
| Sex | Both Genders |
| Age Range | 45-64 |
| Body Types | Overweight |
6 persons with type II diabetes subject to Vanadium treatment for 3 weeks at 100mg daily improved glucose tolerance and insulin sensitivity in response to glucose by enhancing the actions of insulin; these persisted for 2 weeks after cessation of vanadium.
A trend to reduce triglycerides was noted, but failed to be significant.
